These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 279357

  • 1. Delayed hypersensitivity skin reactions in the induction phase of remission in acute non lymphoid leukemias.
    Vu Van H, Fiere D, Doillon M, Martin C, Coiffier B, Revol L.
    Biomedicine; 1978; 28(3):166-9. PubMed ID: 279357
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic value of delayed-hypersensitivity skin tests and rosette studies in acute non-lymphoid leukemias].
    Vu Van H, Révillard JP, Brochier J, Samarut C, Fière D, Révol L.
    Nouv Rev Fr Hematol (1978); 1978 Nov 25; 20(3):413-22. PubMed ID: 314098
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    Hersh EM, Gutterman JU, Mavligit GM, McCredie KB, Burgess MA, Matthews A, Freireich EJ.
    J Clin Invest; 1974 Aug 25; 54(2):401-8. PubMed ID: 4527189
    [Abstract] [Full Text] [Related]

  • 5. Cellular immune reactions in human acute leukemia.
    Herberman RB.
    Hamatol Bluttransfus; 1974 Aug 25; 14():107-18. PubMed ID: 4615044
    [No Abstract] [Full Text] [Related]

  • 6. The relationship of cellular immunity to prognosis in acute leukemia.
    Toki H, Takahashi Y, Nakanishi N, Naito T, Chen P, Takahashi I, Kitajima K.
    Acta Med Okayama; 1977 Feb 25; 31(1):51-8. PubMed ID: 140590
    [Abstract] [Full Text] [Related]

  • 7. [Can the course of an acute leukemia be predicted?].
    Heim M, Albert WK, Schäfer W, Wahrendorf J, Queisser W.
    Med Klin; 1981 Sep 11; 76(19):537-40. PubMed ID: 6944596
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 11; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 13. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH, Choi SJ, Lee JH, Park JH, Kim H, Joo YD, Lee WS, Zang DY, Kim HJ, Lee KH, Cooperative Study Group A for Hematology.
    Ann Hematol; 2006 Jun 11; 85(6):357-65. PubMed ID: 16575580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.
    Takubo T, Kubota Y, Oguma S, Ueda T, Shibata H, Nakamura H, Masaoka T, Yoshitake J, Ishigami S.
    Blood Cells; 1983 Jun 11; 9(3):501-14. PubMed ID: 6586210
    [Abstract] [Full Text] [Related]

  • 16. [Disorders of humoral and cellular immunity in acute adult leukemia].
    Steruská M, Sakalová A, Gazová S, Drobná V, Chabronová I, Hrubisko M.
    Vnitr Lek; 1979 Jan 11; 25(1):29-33. PubMed ID: 283625
    [No Abstract] [Full Text] [Related]

  • 17. Host-defence mechanisms in surgical patients: a correlative study of the delayed hypersensitivity skin-test response, granulocyte function and sepsis.
    Christou NV.
    Can J Surg; 1985 Jan 11; 28(1):39-46, 49. PubMed ID: 3971221
    [Abstract] [Full Text] [Related]

  • 18. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 11; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
    Hirano M, Uetani T, Morita A, Sako F, Koie K.
    Saishin Igaku; 1971 Oct 11; 26(10):2034-41. PubMed ID: 5288692
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.